APA (7th ed.) Citation

JR, C., S, Y., L, C., GS, P., B, B., B, W., . . . A, K. (2012). Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: Exploratory analyses from the TEMPO trial. Annals of the rheumatic diseases, 71(2), 206. https://doi.org/10.1136/ard.2011.153551

Chicago Style (17th ed.) Citation

JR, Curtis, Yang S, Chen L, Park GS, Bitman B, Wang B, Navarro-Millan I, and Kavanaugh A. "Predicting Low Disease Activity and Remission Using Early Treatment Response to Antitumour Necrosis Factor Therapy in Patients with Rheumatoid Arthritis: Exploratory Analyses from the TEMPO Trial." Annals of the Rheumatic Diseases 71, no. 2 (2012): 206. https://doi.org/10.1136/ard.2011.153551.

MLA (9th ed.) Citation

JR, Curtis, et al. "Predicting Low Disease Activity and Remission Using Early Treatment Response to Antitumour Necrosis Factor Therapy in Patients with Rheumatoid Arthritis: Exploratory Analyses from the TEMPO Trial." Annals of the Rheumatic Diseases, vol. 71, no. 2, 2012, p. 206, https://doi.org/10.1136/ard.2011.153551.